Premium
Digital blood flow and 5‐hydroxytryptamine receptor blockade after ketanserin in patients with Raynaud's phenomenon.
Author(s) -
Marasini B.,
Bassani C.
Publication year - 1990
Publication title -
british journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.216
H-Index - 146
eISSN - 1365-2125
pISSN - 0306-5251
DOI - 10.1111/j.1365-2125.1990.tb05450.x
Subject(s) - ketanserin , blockade , medicine , raynaud disease , blood flow , cardiology , receptor , serotonin , 5 ht receptor
1. The effect of ketanserin on digital blood flow and 5‐ hydroxytryptamine (5‐HT)‐induced platelet aggregation was studied in 18 patients with Raynaud's phenomenon. 2. Measurements were made before and after a single dose of 20 mg ketanserin and again after 1 month of continuous treatment with 20 mg ketanserin three times a day. 3. Digital blood flow was assessed by changes in digital pulse volume; platelet aggregation by changes in light transmission after challenge with 10(‐5) M 5‐HT. 4. Ketanserin induced a rise in digital blood flow and blocked the platelet response to 5‐HT; the two events were not correlated and were independent of subjective improvement. 5. These data do not support the suggestion that 5‐HT2‐receptor blockade is of major importance in the dilatory effect of ketanserin in Raynaud's phenomenon.